A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

November 30, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Metachromatic Leukodystrophy (MLD)
Interventions
OTHER

No Intervention

As this is an observational study, no intervention will be administered.

Trial Locations (10)

15706

Hospital Clinico Universitario de Santiago, Santiago de Compostela

20014

Hospital Universitario de Donostia, Donostia / San Sebastian

28009

Hospital Universitario Infantil Nino Jesus, Madrid

35016

Hospital Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

41013

Hospital Universitario Virgen del Rocio, Seville

46026

Hospital Universitario y Politecnico La Fe, Valencia

48903

Hospital Universitario de Cruces, Barakaldo

08950

Hospital Sant Joan de Deu, Esplugues de Llobregat

08035

Hospital Universitario Vall dHebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05755568 - A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain | Biotech Hunter | Biotech Hunter